Bart Rijnders to Netherlands
This is a "connection" page, showing publications Bart Rijnders has written about Netherlands.
Connection Strength
0.564
-
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterol Hepatol. 2019 04; 4(4):269-277.
Score: 0.098
-
Case series on acute HCV in HIV-negative men in regular clinical practice: a call for action. Neth J Med. 2018 10; 76(8):374-378.
Score: 0.096
-
The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol. Mycoses. 2018 Sep; 61(9):656-664.
Score: 0.094
-
Acute hepatitis C in HIV-negative men who have sex with men in the Netherlands and Belgium: a call for action. Sex Transm Infect. 2018 06; 94(4):297.
Score: 0.094
-
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial. Lancet HIV. 2017 12; 4(12):e547-e554.
Score: 0.090
-
Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study. Lancet HIV. 2019 03; 6(3):e173-e181.
Score: 0.025
-
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 10; 6(10):782-792.
Score: 0.024
-
High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands. Clin Infect Dis. 2018 04 17; 66(9):1352-1359.
Score: 0.023
-
Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients. AIDS. 2017 06 19; 31(10):1415-1424.
Score: 0.022